Stella Pharma Corporation (TYO:4888)
Japan · Delayed Price · Currency is JPY 316.00
-10.00 (-3.07%)
Oct 28, 2025, 3:30 PM JST
Stella Pharma Revenue
Stella Pharma had revenue of 92.00M JPY in the quarter ending June 30, 2025, with 50.82% growth. This brings the company's revenue in the last twelve months to 992.00M, up 268.77% year-over-year. In the fiscal year ending March 31, 2025, Stella Pharma had annual revenue of 961.00M with 257.25% growth.
Revenue (ttm)
992.00M
Revenue Growth
+268.77%
P/S Ratio
10.84
Revenue / Employee
23.07M
Employees
43
Market Cap
10.75B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 961.00M | 692.00M | 257.25% |
| Mar 31, 2024 | 269.00M | 40.00M | 17.47% |
| Mar 31, 2023 | 229.00M | 129.00M | 129.00% |
| Mar 31, 2022 | 100.00M | -105.00M | -51.22% |
| Mar 31, 2021 | 205.00M | - | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.48T |
| Otsuka Holdings | 2.40T |
| Astellas Pharma | 1.94T |
| Daiichi Sankyo Company | 1.92T |
| Chugai Pharmaceutical | 1.21T |
| Terumo | 1.04T |
| Olympus | 969.02B |
| HOYA Corporation | 876.09B |